SCOTTSDALE, AZ / ACCESSWIRE / June 30, 2022 / Today CBD Life Sciences (OTC PINK:CBDL) through its wholly owned subsidiary, LBC Bioscience Inc. announces today that the company has begun starting a New Laboratory Operation at its retail location CBD Vault.
LBC Bioscience Inc. is constantly ramping up production due to high demand, and the company has started producing a variety of products with the company's new ultramodern machinery. The products the CBD Vault are currently producing in house are tinctures, gummies, cartridges, & more! President & CEO Lisa Nelson states, "With all these new machines, we now have access to create all diverse kinds of products for consumers and we may be able to create something that has never been done before!" Lisa Nelson also said, "By starting this lab operation, this will open up more avenues for revenue along with new product opportunities as we have been able to quadruple our product development over the past couple of weeks to provide large orders to other companies!" Benefits of having the lab include being able to experiment with existing and new products, push out larger quantity orders, & create stronger top of the line products! What differentiates CBD Life Sciences Inc from the competition is all their Full Spectrum Cannabinoids contain over 7 (seven) cannabinoids offering all the benefits the industrial hemp plant has to offer. Due to using CO2 Extraction, you may find; CBD, CBDa, CBG, CBGa, CBN, CBC, & CBDV in all products as well as; Terpenoids, Aminos, Omegas, Saponins, and Flavonoids.
Out of all cannabinoids, cannabidiol is most widely used for therapeutic reasons due to the lack of psychoactive effects. In many medical applications, cannabidiol oil is used, such as anxiety and depression treatment, stress relief, diabetes prevention, pain relief, cancer symptom relief, and inflammation. Due to the increasing adoption of CBD-based products to treat ailments, the global cannabidiol market is anticipated to grow at a lucrative rate over the forecast period. Increasing awareness of cannabidiol's therapeutic benefits has influenced a buyer to buy cannabidiol products, regardless of their cost. As these have a greater profit margin, commercial retailers are now focusing on selling cannabis-based products. Numerous health and wellness retailers are offering CBD-based products, such as Rite Aid, CVS Health, and Walgreens Boots Alliance. In addition, CVS Health decides to offer CBD topicals all over its 800 stores and Walgreens Boots Alliance is selling CBD-containing topicals across 1500 of its stores in the U.S. Report from Fortune Business Insights said that the global cannabidiol (CBD) market size was USD 2,770.8 million in 2020. They also stated that the market is projected to grow from USD 3,675.1 million in 2022 to USD 55,791.3 million in 2028 at a CAGR of 47.49% between 2022 and 2028.
The number of benefits CBD has is tremendous! These benefits may help with behavioral/neurological complications such as ADD/ADHD, anxiety, autism, bipolar, OCD, PTSD, epilepsy, Parkinson's, osteoporosis, and ALS. CBD may also benefit pain management that can stem from headaches/migraines, arthritis, cramps, spinal injuries, and fibromyalgia. CBD has been found to also have gastrointestinal benefits with gastro-disorders and complications such as anorexia, cachexia, Crohn's, diabetes, and nausea. Physical complications/disorders such as muscular dystrophy and even immune system-based deficiencies and other complications such as cancer and hypertension even our bodies way and ability to maintain homeostasis have all been said to benefit from CBD.
https://www.accesswire.com/707119/cbd-life-sciences-inc-cbdl-announces-new-laboratory-operation-launched-at-cbd-vault